Labeler · US market

Teva Parenteral Medicines, Inc.

Teva Parenteral Medicines, Inc. is a US drug labeler with US FDA registrations covering 10 drug concepts (8 currently active) across 39 packages. It is currently the only active US supplier of 2 drugs.

ACTIVE — US

openFDA · updated weekly

Labeler codes0703

Active drugs8

Registrations24 active / 28

Packages39

Sole supplier of2 drugs

Portfolio10 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Carboplatin injection, solution	rx	4	8	SUPPLYING
Paclitaxel injection, solution, concentrate	rx	4	7	SUPPLYING
Sulfamethoxazole And Trimethoprim injection, solution, concentrate	rx	3	6	SUPPLYING
Treprostinil injection, solution	rx	4	4	SUPPLYING
Hydromorphone Hydrochloride injection, solution	rx	3	3	SUPPLYING
Methotrexate injection, solution	rx	3	3	SUPPLYING
Metoclopramide injection, solution	rx	1	2	SUPPLYING
Cisplatin injection, solution	rx	2	2	SUPPLYING
Triamcinolone Acetonide injection, suspension	rx	3	3	DISCONTINUED
Palonosetron Hydrochloride injection, solution	rx	1	1	DISCONTINUED

Sole US supplier

Drugs where this labeler is currently the only active US supplier — a single point of failure if it exits.

Methotrexaterx
Paclitaxelrx

At a glance

TypeLabeler
Labeler codes0703
Filing names1
Drugs (active)8
Drugs (all time)10
US registrations28
Packages39

Recent events

Shortages, recalls, and registration changes across all filing names.

Feb 7, 2018
RECALLRecall (Class I): Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. M…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.